Biomedical Engineering Reference
In-Depth Information
122. Wang XL, Xu R, Lu ZR (2009) A peptide-targeted delivery system with pH-sensitive
amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
J Control Release 134:207-213
123. Cheng H, Zhu JL, Zeng X, Jing Y, Zhang XZ, Zhuo RX (2009) Targeted gene delivery
mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
Bioconjug Chem 20:481-487
124. Thomas M, Kularatne SA, Qi L, Kleindl P, Leamon CP, Hansen MJ, Low PS (2009) Ligand-
targeted delivery of small interfering RNAs to malignant cells and tissues. Ann N Y Acad Sci
1175:32-39
125. Harbottle RP, Cooper RG, Hart SL, Ladhoff A, McKay T, Knight AM, Wagner E, Miller AD,
Coutelle C (1998) An RGD-oligolysine peptide: a prototype construct for integrin-mediated
gene delivery. Hum Gene Ther 9:1037-1047
126. Erbacher P, Remy JS, Behr JP (1999) Gene transfer with synthetic virus-like particles via the
integrin-mediated endocytosis pathway. Gene Ther 6:138-145
127. Suh W, Han SO, Yu L, Kim SW (2002) An angiogenic, endothelial-cell-targeted polymeric
gene carrier 1. Mol Ther 6:664-672
128. Kunath K, Merdan T, Hegener O, Haberlein H, Kissel T (2003) Integrin targeting using RGD-
PEI conjugates for in vitro gene transfer. J Gene Med 5:588-599
129. Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV,
Woodle MC (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted
sterically stabilized nanoparticle. Nucleic Acids Res 32:e149
130. Wang XL, Xu R, Wu X, Gillespie D, Jensen R, Lu ZR (2009) Targeted systemic delivery of a
therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Mol
Pharmaceutics 6:738-746
131. Moffatt S, Wiehle S, Cristiano RJ (2005) Tumor-specific gene delivery mediated by a novel
peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13. Hum Gene
Ther 16:57-67
132. Moffatt S, Wiehle S, Cristiano RJ (2006) A multifunctional PEI-based cationic polyplex for
enhanced systemic p53-mediated gene therapy. Gene Ther 13:1512-1523
133. Wu GY, Wu CH (1987) Receptor-mediated in vitro gene transformation by a soluble DNA
carrier system. J Biol Chem 262:4429-4432
134. Wu GY, Wu CH (1988) Receptor-mediated gene delivery and expression in vivo 738. J Biol
Chem 262:14621-14624
135. Frese J, Wu CH, Wu G (1994) Targeting of genes to the liver with glyoprotein carriers 216.
Adv Drug Deliv Rev 14:137-152
136. Plank C, Zatloukal K, Cotten M, Mechtler K, Wagner E (1992) Gene transfer into
hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed
with an artificial tetra-antennary galactose ligand. Bioconjug Chem 3:533-539
137. Merwin JR, Noell GS, Thomas WL, Chiou HC, DeRome ME, McKee TD, Spitalny GL,
Findeis MA (1994) Targeted delivery of DNA using YEE(GalNAcAH)3, a synthetic glyco-
peptide ligand for the asialoglycoprotein receptor 440. Bioconjug Chem 5:612-620
138. Nishikawa M, Yamauchi M, Morimoto K, Ishida E, Takakura Y, Hashida M (2000) Hepato-
cyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed
with synthetic multi- functional gene delivery system. Gene Ther 7:548-555
139. Kim EM, Jeong HJ, Park IK, Cho CS, Moon HB, Yu DY, Bom HS, Sohn MH, Oh IJ (2005)
Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-
graft-poly(ethylene glycol): in vitro and in vivo studies. J Control Release 108:557-567
140. Jiang HL, Kwon JT, Kim YK, Kim EM, Arote R, Jeong HJ, Nah JW, Choi YJ, Akaike T, Cho
MH, Cho CS (2007) Galactosylated chitosan-graft-polyethylenimine as a gene carrier for
hepatocyte targeting. Gene Ther 14:1389-1398
141. Huang R, Ke W, Liu Y, Jiang C, Pei Y (2008) The use of lactoferrin as a ligand for targeting
the polyamidoamine-based gene delivery system to the brain. Biomaterials 29:238-246
